ANN ARBOR, Michigan. – Metro Detroit is now the site of four COVID-19 vaccine trials. The latest is being held at the University of Michigan and includes a vaccine developed by Oxford University and pharmaceutical company AstraZeneca.
“The most important group is not the doctors, it’s the patients who are ready to participate,” Dr. Daniel Caul said.
2 September 2020: Michigan Coronavirus (COVID-19) cases up to 103,710; Death figure now at 6,509
The university said that 30,000 volunteers would be required to test the vaccine.
Kaul said, “Vaccines are probably the best way to get out of this mess.” “And there are a number of really promising candidates, but they have to prove safe and prove to be effective and that is what the three tests are designed to determine.”
The vaccine uses an inactive form of a cold virus to deliver pieces of coronavirus into the body to trigger an immune response. Of the 30,000 volunteers, 20,000 will receive the actual vaccine, while 10,000 will receive a placebo.
Participants must be over 18 years of age and in good or stable health.
“We definitely want to participate in those who represent those in the community who are getting COVID and getting sick from COVID,” Kaul said. “They are people. Clinical trials often represent people who actually suffer from COVID, and we want people whose status puts them at risk to get COVID, so are essential employees. “
Researchers may not participate in the tests, but Kaul said that if they were given permission.
“Oh, I’ll take it in a heartbeat,” Kaul said. “Maybe I can find another test I’m not a part of.”
Initial tests found no serious side effects from the vaccine. It is also being tested in Britain, India, Brazil and South Africa.
For more information, or to volunteer for vaccine testing, click here.
Copyright 2020 by WDIV ClickOnDetroit – All rights reserved.